Keeping you up to dateLatest Clearstate Healthcare Insights postsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
China’s IVD market – sample report China has been aggressively implementing various policies to… In-vitro diagnostics | Point-of-care testing (POCT) | Segment Trend Report samples | Asia
Thailand’s IVD market – sample report The Centralised Diagnostics (CDx) market in Thailand… In-vitro diagnostics | Point-of-care testing (POCT) | Segment Trend Report samples | Asia
South Korea’s IVD market – sample report The IVD market in South Korea reached US$1.0 billion in… In-vitro diagnostics | Point-of-care testing (POCT) | Segment Trend Report samples | Asia
Vietnam’s IVD market – sample report Vietnam’s IVD market is expected to increase by 2.5% in… In-vitro diagnostics | Point-of-care testing (POCT) | Segment Trend Report samples | Asia | Vietnam
Point-of-care infectious disease testing market In a recent Q&A interview with Clearstate’s global… In-vitro diagnostics | Point-of-care testing (POCT) | Global | IVD Gateway | Point-of-care testing (POCT)
Are there concerns with the supply chain for point-of-care testing reagents and controls in some parts of the world? In a recent Q&A interview, Clearstate’s global managing… In-vitro diagnostics | Point-of-care testing (POCT) | Global | Point-of-care testing (POCT)
What technology will revolutionise the point-of-care testing market? In a recent Q&A interview, Clearstate’s global managing… In-vitro diagnostics | Point-of-care testing (POCT) | Global | Point-of-care testing (POCT)
Essential insights into Vietnam’s in-vitro diagnostics market Vietnam’s IVD market, estimated at US$419.2m, faced a… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Infectious Diseases Testing Monitor | Point-of-care testing (POCT) | Asia | Vietnam
Point-of-care testing: promises and challenges Point-of-care testing (POCT) has long been touted as a… In-vitro diagnostics | Point-of-care testing (POCT) | Uncategorised
Growth opportunities for IVD companies in APAC and LATAM Growth opportunities from covid-19 have helped fuel rapid… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Point-of-care testing (POCT) | Tissue Diagnostics (TDx) | Americas | Asia
How Indonesia’s healthcare transformation will impact its IVD market Indonesia’s in-vitro diagnostics (IVD) market will recover… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Asia | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
How inflation will impact Brazil’s IVD market Brazil’s in-vitro diagnostics (IVD) market will recover in… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Uncategorised | Americas
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now